Who to call at Flagship Pioneering, and when
Fundz watches for the moments Flagship Pioneering starts buying, and tells you who to reach.
- An alert the day Flagship Pioneering raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Flagship Pioneering, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Flagship Pioneering. With Fundz connected, it knows.
Flagship Pioneering and Pfizer Partner to Develop T Cell-Targeted Immune Medicines for Prostate Cancer.
Contract Type
partnership
Description
Flagship Pioneering has announced a strategic partnership with Pfizer to optimize TCR bispecifics for metastatic prostate cancer. This collaboration leverages Repertoire's DECODE platform to identify new immune medicines and accelerate cancer treatment development.
Quick answer
Flagship Pioneering and Pfizer Partner to Develop T Cell-Targeted Immune Medicines for Prostate Cancer. (December 22, 2025). Flagship Pioneering is based in Cambridge, Maryland, United States.
- What agreement did Flagship Pioneering announce on December 22, 2025?
- Flagship Pioneering has announced a strategic partnership with Pfizer to optimize TCR bispecifics for metastatic prostate cancer. This collaboration leverages Repertoire's DECODE platform to identify new immune medicines and accelerate cancer treatment development.
- What does Flagship Pioneering do?
- Flagship Pioneering conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability.
- Where is Flagship Pioneering based?
- Flagship Pioneering is based in Cambridge, Maryland, United States.
Source: Fundz verified event record.
Related People
Agreement Insights
What this usually meansFlagship Pioneering signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.